Improvement of skin condition and intestinal microbiota via Heyndrickxia coagulans SANK70258 intake: A placebo-controlled, randomized, double-blind, parallel-group comparative study.
Naoyuki TogawaRyouichi YamadaYoshinori AokiShouhei SuehiroNoriyoshi UchidaAkane HasedaHiroyo Kagami-KatsuyamaNaoyuki HonmaJun NishihiraPublished in: Nutrition (Burbank, Los Angeles County, Calif.) (2024)
H. coagulans SANK70258 can improve skin health by improving the intestinal lining. This probiotic reduces the levels of intestinal putrefactive products and advanced glycation end-product levels in feces, suggesting that it may affect not only skin health but also systemic tissues such as the liver.
Keyphrases
- placebo controlled
- double blind
- phase iii
- soft tissue
- healthcare
- public health
- clinical trial
- phase ii
- wound healing
- mental health
- study protocol
- health information
- phase ii study
- open label
- gene expression
- health promotion
- squamous cell carcinoma
- body mass index
- randomized controlled trial
- human health
- climate change
- drug induced